Anticoagulant Action Initiative

Hospitalized patients with acute medical illnesses are at significant risk for venous thromboembolism (VTE) during and after a hospital stay. Strategies for optimal pharmacologic VTE thromboprophylaxis are evolving but necessary to protect high-risk patients after hospital discharge.

NATF is proud to launch the Anticoagulation Action Initiative to help drive the appropriate use of VTE prophylaxis in medically ill patients. Developed by a panel of global experts, this consensus document explores the most recent data on extended-duration prophylaxis and serves as a practical, contemporary guide for frontline providers and stakeholders, including hospitalists, internal medicine practitioners, pharmacists, nurse practitioners, physician assistants, subspecialty clinicians, and hematology, pulmonary medicine, and cardiovascular medicine staff.

To view the full journal, click here.

Atrial Fibrillation Action Initiative

The NATF Atrial Fibrillation Action Initiative identifies multidisciplinary best practices for stroke prevention in atrial fibrillation (Afib). Our mission is to provide a comprehensive yet concise consensus document focused on stroke and bleeding risk assessment in patients with Afib as well as anticoagulation options and management. We intend for this practical document to serve as a reference for the entire medical community involved in the care of patients with Afib: primary care, emergency medicine, pharmacy, and cardiovascular medicine.

To view the full journal, click here.